Alliance Global Partners Archives

Markets

AGP ups OpGen PT to $11.30 from reverse-split adjusted $8

Alliance Global Partners raised its price target for OpGen (NASDAQ:OPGN) to $11 from a reverse-split adjusted $8 after an analysis of its proposed merger with Curetis (Euronext:CURE), an infectious disease molecular...

September 30, 2019

Markets

AGP starts coverage of 4 cannabis companies at buy

Alliance Global Partners launched coverage of four cannabis companies – Acreage Holdings (CSE:ACRG; OTCQX:ACRGF), GrowGeneration (OTCQX:GRWG), Village Farms International (TSX:VFF) and Green Thumb Industries...

September 19, 2019

Markets

Analysts up T2 Biosystems price targets

Analysts for Alliance Global Partners and SVB Leerink raised their price targets for T2 Biosystems (NASDAQ:TTOO) following a conference call that updated multiple positive developments. Ben Haynor of AGP writes that the...

September 12, 2019

Markets

AGP starts coverage of Itamar Medical at buy; PT $15.50

Alliance Global Partners initiated coverage of Itamar Medical (NASDAQ:ITMR) with a “buy” rating and $15.50 price target. The stock closed at $9.10 on Aug. 29. “We see Itamar as the technology leader in home sleep...

August 30, 2019

Tag - Alliance Global Partners

AGP ups OpGen PT to $11.30 from reverse-split adjusted $8

AGP starts coverage of 4 cannabis companies at buy

Analysts up T2 Biosystems price targets

AGP starts coverage of Itamar Medical at buy; PT $15.50

Follow Us

Subscribe

General

More

Subscribe